Schedule and concentration dependent increase of coagulation times and complement split products in phase I/II trials of an antisense oligonucleotide targeted to protein kinase C-alpha(ISIS 3521/ISI641A). Advani, R., Lum, B. L., Fisher, G. A., Grant, P., Halsey, J., Yuen, A., Holmland, J. T., Kwoh, T. J., Dorr, A., Geary, R., Sikic, B. I. AMER SOC HEMATOLOGY. 1999: 94B

View details for Web of Science ID 000083790700428